Kubota Pharmaceutical Holdings , Ltd. Profit Margin

The latest profit margin for 4596.T is -5389.13% as of June 2026. That compares with -3690.16% in the prior-year period — down 46.0% year over year. That is below the Healthcare sector average of 9.48%. Investors often review this figure alongside Kubota Pharmaceutical Holdings , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 4596.T's profit margin moved from -3690.16% to -5389.13% — a 46.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Kubota Pharmaceutical Holdings , Ltd.'s valuation or profitability profile.

Against Healthcare companies, 4596.T currently prints -5389.13% for profit margin, while the sector average sits near 9.48%. That is roughly 56941.6% below the sector mean. Large gaps often invite a closer look at Kubota Pharmaceutical Holdings , Ltd.'s growth, margins, and balance sheet.

Profit Margin shows how effectively Kubota Pharmaceutical Holdings , Ltd. converts resources into returns. At -5389.13%, 4596.T may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -3690.16% in the prior-year period — down 46.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting 4596.T's profit margin (-5389.13%), review year-over-year change from -3690.16%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.